Mutations in exon 1 of MECP2B are not a common cause of X-linked mental retardation in males [1]

European Journal of Human Genetics

Volumn 13, Issue 5, 2005, Pages 523-524

  Poirier, Karine ^a   Francis, Fiona ^a   Hamel, Ben ^b   Moraine, Claude ^c   Fryns, Jean Pierre ^d   Ropers, Hans H ^e   Chelly, Jamel ^a   Bienvenu, Thierry ^a  

^a INSTITUT COCHIN   (France)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CHU BRETONNEAU   (France)

^d Clinical Genetics Unit   (Belgium)

^e MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 2B; UNCLASSIFIED DRUG;

CHROMOSOME ANALYSIS; CHROMOSOME XQ; COGNITIVE DEFECT; COHORT ANALYSIS; COMPUTER SYSTEM; DATA BASE; DNA SYNTHESIS; EXON; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; HUMAN; LETTER; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETT SYNDROME; SEQUENCE ANALYSIS; X LINKED MENTAL RETARDATION;

CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EXONS; GENETIC SCREENING; HUMANS; MALE; MENTAL RETARDATION, X-LINKED; METHYL-CPG-BINDING PROTEIN 2; MUTATION; REPRESSOR PROTEINS; RETT SYNDROME;

EID: 18844363657     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201399     Document Type: Letter

References (12)

1. Clayton-Smith J, Watson P, Ramsden S, Black GC: Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 2000; 356: 830-832.
2. Moog U, Smeets EE, van Roozendaal KE et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 2003; 7: 5-12.
3. Orrico A, Lam C, Galli L et al: MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 2000; 481: 285-288.
4. Couvert P, Bienvenu T, Aquaviva C et al: MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001; 10: 941-946.
5. Winnepenninckx B, Errijgers V, Hayez-Delatte F, Reyniers E, Frank Kooy R: Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening? Hum Mutat 2002; 20: 249-252.
6. Kleefstra T, Yntema HG, Nillesen WM et al: MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur J Hum Genet 2004; 12: 24-28.
7. Gomot M, Gendrot C, Verloes A et al: MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype-geno-type correlation. Am J Med Genet 2003; 123A: 129-139.
8. Mnatzakanian GN, Lohi H, Munteanu I et al: A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004; 36: 339-341.
9. Kriaucionis S, Bird A: The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 2004; 32: 1818-1823.
10. Evans JC, Archer HL, Whatley SD, Kerr A, Clarke A, Butler R: Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. Eur J Hum Genet 2005; 13: 124-126.
11. Harvey C, Alfred SE, Mnatzakanian GN et al: Screening for mutations in exon 1 of the Rett syndrome gene, MECP2, among individuals with autism and with mental retardation. Am J Hum Genet 2004; abstract 2274.
12. Bleoo SL, Bridge PJ, Innes AM, Parboosingh JS: Mutation analysis of MECP2A and MECP2B in patients referred for Rett syndrome. Am J Hum Genet 2004; abstract 2626.